West Pharmaceutical Services WST
NYSE WST
$353.88 +1.07 (+0.30%)
At close: Aug 20, 2026 · 4:00 PM EDT

West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2026)

West Pharmaceutical Services (WST) posted Cash from Restructuring of $1.0 million for Q2 2026, up 11.11% sequentially from $900000.0 in Q1 2026, and up 25.0% YoY from $800000.0 in Q2 2025.

West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2026) Analysis & Trends

West Pharmaceutical Services has reported Cash from Restructuring for 4 years, with the latest figure at $1.0 million in Q2 2026.

  • Quarterly Cash from Restructuring rose 25.0% year-over-year to $1.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.5 million (up 118.75% YoY) and the FY2025 annual result came in at $5.4 million, changed N/A from the prior year.
  • Cash from Restructuring improved to $1.0 million in Q2 2026 per WST's latest filing, from $900000.0 in the prior quarter.
  • Over five years, Cash from Restructuring peaked at $1.0 million in Q2 2026 and troughed at $800000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 132.71 Bn 127.50 Bn 1.96 Bn
2 Becton Dickinson 51.57 Bn 50.71 Bn 2.32 Bn
3 Alcon 35.52 Bn 34.17 Bn 1.68 Bn
4 Resmed 33.28 Bn 31.81 Bn 861.22 Mn
5 Medline 27.86 Bn 25.18 Bn 2.22 Bn
6 West Pharmaceutical Services 25.15 Bn 24.71 Bn 329.20 Mn
7 Solventum 15.31 Bn 14.91 Bn 1.29 Bn
8 Cooper Companies 14.86 Bn 14.72 Bn 735.40 Mn
9 Baxter International 13.63 Bn 11.48 Bn 1.03 Bn
10 Align Technology 11.37 Bn 10.27 Bn 757.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 900,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 800,000.00
Dec 31, 2019 700,000.00
Sep 30, 2019 1.20 Mn
Jun 30, 2019 100,000.00
Mar 31, 2019 300,000.00
Dec 31, 2018 1.40 Mn
Sep 30, 2018 400,000.00
Jun 30, 2018 300,000.00
Mar 31, 2018 100,000.00